Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tivity Health (TVTY)

Tivity Health (TVTY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Tivity Health (TVTY) Q1 Earnings and Revenues Lag Estimates

Tivity Health (TVTY) delivered earnings and revenue surprises of -4.76% and 4.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TVTY : 32.22 (+0.16%)
OCX : 1.1100 (-0.89%)
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates

Surgery Partners (SGRY) delivered earnings and revenue surprises of -80% and 2.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SGRY : 39.70 (+2.35%)
TVTY : 32.22 (+0.16%)
TIVITY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Tivity Health, Inc. - TVTY

Kuznicki Law PLLC is investigating the proposed sale of Tivity Health, Inc. (NasdaqGS: TVTY) to Stone Point Capital. Under the terms of the proposed transaction, shareholders of Tivity will receive only...

TVTY : 32.22 (+0.16%)
TIVITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tivity Health, Inc. - TVTY

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Tivity Health, Inc. (NasdaqGS: TVTY) to Stone...

TVTY : 32.22 (+0.16%)
NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of 76.47% and 1.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

NVCR : 74.70 (+0.88%)
TVTY : 32.22 (+0.16%)
TIVITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tivity Health, Inc. - TVTY

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Tivity Health, Inc. (NasdaqGS: TVTY) to Stone...

TVTY : 32.22 (+0.16%)
Tivity Health (TVTY) Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Tivity Health, Inc. Is Fair to Shareholders

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Tivity Health, Inc. (NASDAQ: TVTY) to funds managed by Stone Point Capital for $32.50 in cash per share is fair to Tivity...

TVTY : 32.22 (+0.16%)
Tivity Health (TVTY) Moves 5.2% Higher: Will This Strength Last?

Tivity Health (TVTY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the...

TVTY : 32.22 (+0.16%)
IONM : 2.40 (+1.35%)
Tivity Health Reaches Analyst Target Price

In recent trading, shares of Tivity Health Inc have crossed above the average analyst 12-month target price of $30.67, changing hands for $32.10/share. When a stock reaches the target an analyst has...

TVTY : 32.22 (+0.16%)
Is Tivity Health (TVTY) a Suitable Stock for Value Investors?

Let's see if Tivity Health, Inc. (TVTY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

TVTY : 32.22 (+0.16%)

Barchart Exclusives

Stock Market This Week: Five Themes to Watch
With recession fears spiking following a rough series of trades in the equities sector, investors may need to prepare for an unwinding of the post-COVID boom. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar